oa Arab gene geography: From population diversities to personalized medical genomics

References

1. US Census Bureau. http://www.census.gov/population/international/data/idb/informationGateway.phpvisited: 2.3.2014.
2. Hunter-Zinck H, Musharoff S, Salit J, Al-Ali KA, Chouchane L, Gohar A, Matthews R, Butler MW, Fuller J, Hackett NR, Crystal RG, Clark AG. Population genetic structure of the people of Qatar. Am J Hum Genet. 2010; 87:1:17–25.
   [Google Scholar]
3. Liu H, Prugnolle F, Manica A, Balloux F. A geographically explicit genetic model of worldwide human-settlement history. Am J Hum Genet. 2006; 79:2:230–237.
   [Google Scholar]
4. Ferembach D. Human remains from the epipaleolithic period in the Taforalt grotto in eastern Morocco. C R Hebd Seances Acad Sci. 1959; 248:24:3465–3467.
   [Google Scholar]
5. Bouzouggar A, Barton N, Vanhaeren M, d'Errico F, Collcutt S, Higham T, Hodge E, Parfitt S, Rhodes E, Schwenninger JL, Stringer C, Turner E, Ward S, Moutmir A, Stambouli A. 82,000-year-old shell beads from North Africa and implications for the origins of modern human behavior. Proc Natl Acad Sci U S A. 2007; 104:24:9964–9969.
   [Google Scholar]
6. Relethford JH. Genetic evidence and the modern human origins debate. Heredity. 2008; 100:6:555–563.
   [Google Scholar]
7. Fernandes V, Alshamali F, Alves M, Costa MD, Pereira JB, Silva NM, Cherni L, Harich N, Cerny V, Soares P, Richards MB, Pereira L. The Arabian cradle: Mitochondrial relicts of the first steps along the southern route out of Africa. Am J Hum Genet. 2012; 90:2:347–355.
   [Google Scholar]
8. Bailey GN, Flemming NC, King GCP, Lambeck K, Momber G, Moran LJ, Al-Sharekh A, Vita-Finzi C. Coastlines, submerged landscapes, and human evolution: The Red Sea Basin and the Farasan Islands. J Island Coastal Archaeol. 2007; 2::127–160.
   [Google Scholar]
9. Cerný V, Mulligan CJ, Rídl J, Zaloudková M, Edens CM, Hájek M, Pereira L. Regional differences in the distribution of the sub-Saharan, West Eurasian, and South Asian mtDNA lineages in Yemen. Am J Phys Anthropol. 2008; 136:2:128–137.
   [Google Scholar]
10. Abu-Amero KK, Hellani A, González AM, Larruga JM, Cabrera VM, Underhill PA. Saudi Arabian Y-Chromosome diversity and its relationship with nearby regions. BMC Genet. 2009; 10::59.
    [Google Scholar]
11. Cadenas AM, Zhivotovsky LA, Cavalli-Sforza LL, Underhill PA, Herrera RJ. Y-chromosome diversity characterizes the Gulf of Oman. Eur J Hum Genet. 2008; 16:3:374–386.
    [Google Scholar]
12. Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987; 325:6099:31–36.
    [Google Scholar]
13. Ingman M, Kaessmann H, Pääbo S, Gyllensten U. Mitochondrial genome variation and the origin of modern humans. Nature. 2000; 408:6813:708–713.
    [Google Scholar]
14. Luis JR, Rowold DJ, Regueiro M, Caeiro B, Cinnioğlu C, Roseman C, Underhill PA, Cavalli-Sforza LL, Herrera RJ. The Levant versus the Horn of Africa: Evidence for bidirectional corridors of human migrations. Am J Hum Genet. 2004; 74:3:532–544.
    [Google Scholar]
15. Pérez-Miranda AM, Alfonso-Sánchez MA, Peña JA, Herrera RJ. Qatari DNA variation at a crossroad of human migrations. Hum Hered. 2006; 61:2:67–79.
    [Google Scholar]
16. Ferri G, Tofanelli S, Alù M, Taglioli L, Radheshi E, Corradini B, Paoli G, Capelli C, Beduschi G. Y-STR variation in Albanian populations: Implications on the match probabilities and the genetic legacy of the minority claiming an Egyptian descent. Int J Legal Med. 2010; 124:5:363–370.
    [Google Scholar]
17. González-Pérez E, Esteban E, Via M, Gayà-Vidal M, Athanasiadis G, Dugoujon JM, Luna F, Mesa MS, Fuster V, Kandil M, Harich N, Bissar-Tadmouri N, Saetta A, Moral P. Population relationships in the Mediterranean revealed by autosomal genetic data (Alu and Alu/STR compound systems). Am J Phys Anthropol. 2010; 141:3:430–439.
    [Google Scholar]
18. Moorjani P, Patterson N, Hirschhorn JN, Keinan A, Hao L, Atzmon G, Burns E, Ostrer H, Price AL, Reich D. The history of African gene flow into Southern Europeans, Levantines, and Jews. PLoS Genet. 2011; 7:4:e1001373.
    [Google Scholar]
19. Ke Y, Su B, Song X, Lu D, Chen L, Li H, Qi C, Marzuki S, Deka R, Underhill P, Xiao C, Shriver M, Lell J, Wallace D, Wells RS, Seielstad M, Oefner P, Zhu D, Jin J, Huang W, Chakraborty R, Chen Z, Jin L. African origin of modern humans in East Asia: A tale of 12,000 Y chromosomes. Science. 2001; 292:5519:1151–1153.
    [Google Scholar]
20. Maca-Meyer N, González AM, Larruga JM, Flores C, Cabrera VM. Major genomic mitochondrial lineages delineate early human expansions. BMC Genet. 2001; 2::13.
    [Google Scholar]
21. Underhill PA, Passarino G, Lin AA, Shen P, Mirazón Lahr M, Foley RA, Oefner PJ, Cavalli-Sforza LL. The phylogeography of Y chromosome binary haplotypes and the origins of modern human populations. Ann Hum Genet. 2001; 65:Pt 1:43–62.
    [Google Scholar]
22. Lahr MM, Field JS. Assessment of the southern dispersal: GIS-based analyses of potential routes at oxygen isotopic stage 4. J World Prehistory. 2005; 19::1–45.
    [Google Scholar]
23. Manni F, Leonardi P, Barakat A, Rouba H, Heyer E, Klintschar M, McElreavey K, Quintana-Murci L. Y-chromosome analysis in Egypt suggests a genetic regional continuity in Northeastern Africa. Hum Biol. 2002; 74:5:645–658.
    [Google Scholar]
24. Ennafaa H, Cabrera VM, Abu-Amero KK, González AM, Amor MB, Bouhaha R, Dzimiri N, Elgaaïed AB, Larruga JM. Mitochondrial DNA haplogroup H structure in North Africa. BMC Genet. 2009; 10::8.
    [Google Scholar]
25. Rowold DJ, Luis JR, Terreros MC, Herrera RJ. Mitochondrial DNA geneflow indicates preferred usage of the Levant Corridor over the Horn of Africa passageway. J Hum Genet. 2007; 52:5:436–447.
    [Google Scholar]
26. Saleheen D, Frossard PM. The cradle of the ΔF508 mutation. J Ayub Med Coll Abbottabad. 2008; 20:4:157–160.
    [Google Scholar]
27. Obeid T, Tadmouri GO. Initial results of a pilot Arab human variome project. In: Tadmouri GOTaleb Al Ali MAl Khaja N, eds. Genetic Disorders in the Arab World: Qatar. Dubai, United Arab Emirates: Centre for Arab Genomic Studies 2012.
    [Google Scholar]
28. Rose JI. New light on human prehistory in the Arabo-Persian Gulf Oasis. Curr Anthropol. 2010; 51::849–883.
    [Google Scholar]
29. Al-Zahery N, Pala M, Battaglia V, Grugni V, Hamod MA, Hooshiar Kashani B, Olivieri A, Torroni A, Santachiara-Benerecetti AS, Semino O. In search of the genetic footprints of Sumerians: A survey of Y-chromosome and mtDNA variation in the Marsh Arabs of Iraq. BMC Evol Biol. 2011; 11::288.
    [Google Scholar]
30. Grmek MD. Malaria in the eastern Mediterranean in prehistory and antiquity. Parassitologia. 1994; 36::1–6.
    [Google Scholar]
31. de Zulueta J. Malaria and ecosystems: From prehistory to posteradication. Parassitologia. 1994; 36::7–15.
    [Google Scholar]
32. Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, Beerli P, Su XZ. Early origin and recent expansion of Plasmodium falciparum. Science. 2003; 300:5617:318–321.
    [Google Scholar]
33. Angel JL. Porotic hyperostosis, anemias, malarias, and marshes in the prehistoric Eastern Mediterranean. Science. 1966; 153::760–763.
    [Google Scholar]
34. Carter R, Mendis KN. Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev. 2002; 15::564–594.
    [Google Scholar]
35. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005; 77::171–192.
    [Google Scholar]
36. Ziskind B, Halioua B. La tuberculose en ancienne Egypte. Rev Mal Respir. 2007; 24:10:1277–1283.
    [Google Scholar]
37. Karlsson EK, Kwiatkowski DP, Sabeti PC. Natural selection and infectious disease in human populations. Nat Rev Genet. 2014; 15:6:379–393.
    [Google Scholar]
38. Poolman EM, Galvani AP. Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface. 2007; 4:12:91–98.
    [Google Scholar]
39. Stiehm ER. Disease versus disease: How one disease may ameliorate another. Pediatrics. 2006; 117:1:184–191.
    [Google Scholar]
40. Abu-Amero KK, Larruga JM, Cabrera VM, González AM. Mitochondrial DNA structure in the Arabian Peninsula. BMC Evol Biol. 2008; 8::45.
    [Google Scholar]
41. Bar-Yosef O. The Natufian culture in the Levant, threshold to the origins of agriculture. Evol Anthropol. 1998; 6::159–177.
    [Google Scholar]
42. AlShamali F, Pereira L, Budowle B, Poloni ES, Currat M. Local population structure in Arabian Peninsula revealed by Y-STR diversity. Hum Hered. 2009; 68:1:45–54.
    [Google Scholar]
43. Fu W, O'Connor TD, Jun G, Kang HM, Abecasis G, Leal SM, Gabriel S, Rieder MJ, Altshuler D, Shendure J, Nickerson DA, Bamshad MJ, NHLBI Exome Sequencing Project , Akey JM. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013; 493:7431:216–220.
    [Google Scholar]
44. Beech CM, Liyanarachchi S, Shah NP, Sturm AC, Sadiq MF, de la Chapelle A, Tanner SM. Ancient founder mutation is responsible for Imerslund-Gräsbeck Syndrome among diverse ethnicities. Orphanet J Rare Dis. 2011; 6::74.
    [Google Scholar]
45. Terreros MC, Rowold DJ, Mirabal S, Herrera RJ. Mitochondrial DNA and Y-chromosomal stratification in Iran: Relationship between Iran and the Arabian Peninsula. J Hum Genet. 2011; 56:3:235–246.
    [Google Scholar]
46. Arredi B, Poloni ES, Paracchini S, Zerjal T, Fathallah DM, Makrelouf M, Pascali VL, Novelletto A, Tyler-Smith C. A predominantly neolithic origin for Y-chromosomal DNA variation in North Africa. Am J Hum Genet. 2004; 75:2:338–345.
    [Google Scholar]
47. Kujanová M, Pereira L, Fernandes V, Pereira JB, Cerný V. Near eastern neolithic genetic input in a small oasis of the Egyptian Western Desert. Am J Phys Anthropol. 2009; 140:2:336–346.
    [Google Scholar]
48. Lucotte G, Aouizérate A, Berriche S. Y-chromosome DNA haplotypes in north African populations. Hum Biol. 2000; 72:3:473–480.
    [Google Scholar]
49. Lucotte G, Mercier G. Brief communication: Y-chromosome haplotypes in Egypt. Am J Phys Anthropol. 2003; 121:1:63–66.
    [Google Scholar]
50. Irish JD. The Iberomaurusian enigma: North African progenitor or dead end? J Hum Evol. 2000; 39::393–410.
    [Google Scholar]
51. Beech M, Cuttler R, Moscrop D, Kallweit H, Martin J. New evidence for the Neolithic settlement of Marawah Island, Abu Dhabi, United Arab Emirates. PSAS. 2005; 35::37–56.
    [Google Scholar]
52. Bahri R, El Moncer W, Al-Batayneh K, Sadiq M, Esteban E, Moral P, Chaabani H. Genetic differentiation and origin of the Jordanian population: An analysis of Alu insertion polymorphisms. Genet Test Mol Biomarkers. 2012; 16:5:324–329.
    [Google Scholar]
53. Omberg L, Salit J, Hackett N, Fuller J, Matthew R, Chouchane L, Rodriguez-Flores JL, Bustamante C, Crystal RG, Mezey JG. Inferring genome-wide patterns of admixture in Qataris using fifty-five ancestral populations. BMC Genet. 2012; 13::49.
    [Google Scholar]
54. Garcia-Bertrand R, Simms TM, Cadenas AM, Herrera RJ. United Arab Emirates: Phylogenetic relationships and ancestral populations. Gene. 2014; 533:1:411–419.
    [Google Scholar]
55. Walter H, Matsumoto H, De Stefano GF. Gm and Km allotypes in four Sardinian population samples. Am J Phys Anthropol. 1991; 86:1:45–50.
    [Google Scholar]
56. Tadmouri GO, Garguier N, Demont J, Perrin P, Başak AN. History and origin of beta-thalassemia in Turkey: Sequence haplotype diversity of beta-globin genes. Hum Biol. 2001; 73:5:661–674.
    [Google Scholar]
57. Gérard N, Berriche S, Aouizérate A, Diéterlen F, Lucotte G. North African Berber and Arab influences in the western Mediterranean revealed by Y-chromosome DNA haplotypes. Hum Biol. 2006; 78:3:307–316.
    [Google Scholar]
58. Zalloua PA, Xue Y, Khalife J, Makhoul N, Debiane L, Platt DE, Royyuru AK, Herrera RJ, Hernanz DF, Blue-Smith J, Wells RS, Comas D, Bertranpetit J, Tyler-Smith C, Genographic Consortium . Y-chromosomal diversity in Lebanon is structured by recent historical events. Am J Hum Genet. 2008a; 82::873–882.
    [Google Scholar]
59. Loirat F, Hazout S, Lucotte G. G542X as a probable Phoenician cystic fibrosis mutation. Hum Biol. 1997; 69:3:419–425.
    [Google Scholar]
60. Zalloua PA, Platt DE, El Sibai M, Khalife J, Makhoul N, Haber M, Xue Y, Izaabel H, Bosch E, Adams SM, Arroyo E, López-Parra AM, Aler M, Picornell A, Ramon M, Jobling MA, Comas D, Bertranpetit J, Wells RS, Tyler-Smith C, Genographic Consortium . Identifying genetic traces of historical expansions: Phoenician footprints in the Mediterranean. Am J Hum Genet. 2008b; 83::633–642.
    [Google Scholar]
61. Zahed L, Demont J, Bouhass R, Trabuchet G, Hänni C, Zalloua P, Perrin P. Origin and history of the IVS-I-110 and codon 39 beta-thalassemia mutations in the Lebanese population. Hum Biol. 2002; 74::837–847.
    [Google Scholar]
62. Fattoum S, Abbes S. Some data on the epidemiology of hemoglobinopathies in Tunisia. Hemoglobin. 1985; 9::423–429.
    [Google Scholar]
63. Ben Abdeladhim A, Aïssaoui B, Boussen M, Homozygous O. Arab hemoglobinopathy in a Tunisian family. Apropos of a case. Tunis Med. 1987; 65::571–574.
    [Google Scholar]
64. Labie D, Elion J, Beldjord C. On the diversity of beta-globin mutations, a reflection of recent historic events in Israel. Am J Hum Genet. 1994; 55:6:1284–1285.
    [Google Scholar]
65. Salem AH, Badr FM, Gaballah MF, Pääbo S. The genetics of traditional living: Y-chromosomal and mitochondrial lineages in the Sinai Peninsula. Am J Hum Genet. 1996; 59:3:741–743.
    [Google Scholar]
66. Gutala R, Carvalho-Silva DR, Jin L, Yngvadottir B, Avadhanula V, Nanne K, Singh L, Chakraborty R, Tyler-Smith C. A shared Y-chromosomal heritage between Muslims and Hindus in India. Hum Genet. 2006; 120:4:543–551.
    [Google Scholar]
67. Gomes MP, da Costa MG, Braga LB, Cordeiro-Ferreira NT, Loi A, Pirastu M, Cao A. Beta-thalassemia mutations in the Portuguese population. Hum Genet. 1988; 78:1:13–15.
    [Google Scholar]
68. Jassim N, Merghoub T, Pascaud O, al Mukharraq H, Ducrocq R, Labie D, Elion J, Krishnamoorthy R, Arrayed SA. Molecular basis of beta-thalassemia in Bahrain: An epicenter for a Middle East specific mutation. Ann N Y Acad Sci. 1998; 850::407–409.
    [Google Scholar]
69. Al-Ali AK, Al-Ateeq S, Imamwerdi BW, Al-Sowayan S, Al-Madan M, Al-Muhanna F, Bashaweri L, Qaw F. Molecular Bases of beta-thalassemia in the Eastern Province of Saudi Arabia. J Biomed Biotechnol. 2005a; 2005:4:322–325.
    [Google Scholar]
70. Purdey M. The pathogenesis of Machado Joseph Disease: A high manganese/low magnesium initiated CAG expansion mutation in susceptible genotypes? J Am Coll Nutr. 2004; 23:6:715S–729S.
    [Google Scholar]
71. Mittal U, Srivastava AK, Jain S, Jain S, Mukerji M. Founder haplotype for Machado-Joseph disease in the Indian population: Novel insights from history and polymorphism studies. Arch Neurol. 2005; 62:4:637–640.
    [Google Scholar]
72. Haj Khelil A, Laradi S, Miled A, Tadmouri GO, Ben Chibani J, Perrin P. Clinical and molecular aspects of haemoglobinopathies in Tunisia. Clin Chim Acta. 2004; 340::127–137.
    [Google Scholar]
73. Loueslati BY, Cherni L, Khodjet-Elkhil H, Ennafaa H, Pereira L, Amorim A, Ben Ayed F, Ben Ammar Elgaaied A. Islands inside an island: Reproductive isolates on Jerba island. Am J Hum Biol. 2006; 18:1:149–153.
    [Google Scholar]
74. González AM, Karadsheh N, Maca-Meyer N, Flores C, Cabrera VM, Larruga JM. Mitochondrial DNA variation in Jordanians and their genetic relationship to other Middle East populations. Ann Hum Biol. 2008; 35:2:212–231.
    [Google Scholar]
75. Jalal SD, Al-Allawi NA, Bayat N, Imanian H, Najmabadi H, Faraj A. β-Thalassemia mutations in the Kurdish population of northeastern Iraq. Hemoglobin. 2010; 34:5:469–476.
    [Google Scholar]
76. Tadmouri GO, Nair P, Obeid T, Al Ali MT, Al Khaja N, Hamamy HA. Consanguinity and reproductive health among Arabs. Reprod Health. 2009; 6::17.
    [Google Scholar]
77. AlKuraya FS. Autozygome decoded. Genet Med. 2010; 12:12:765–771.
    [Google Scholar]
78. Fadhlaoui-Zid K, Martinez-Cruz B, Khodjet-el-khil H, Mendizabal I, Benammar-Elgaaied A, Comas D. Genetic structure of Tunisian ethnic groups revealed by paternal lineages. Am J Phys Anthropol. 2011; 146:2:271–280.
    [Google Scholar]
79. Tadmouri GO. Genetic disorders in Arabs. In: Tadmouri GOTaleb Al Ali MAl Khaja N, eds. Genetic Disorders in the Arab World: Qatar. Dubai, United Arab Emirates: Centre for Arab Genomic Studies 2012.
    [Google Scholar]
80. Daoud BB, Mosbehi I, Préhu C, Chaouachi D, Hafsia R, Abbes S. Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Tunisia. Pathol Biol (Paris). 2008; 56:5:260–267.
    [Google Scholar]
81. Nafa K, Reghis A, Osmani N, Baghli L, Benabadji M, Kaplan JC, Vulliamy TJ, Luzzatto L. G6PD Aures: A new mutation (48 Ile‐‐>Thr) causing mild G6PD deficiency is associated with favism. Hum Mol Genet. 1993; 2:1:81–82.
    [Google Scholar]
82. Niazi GA, Adeyokunnu A, Westwood B, Beutler E. Neonatal jaundice in Saudi newborns with G6PD Aures. Ann Trop Paediatr. 1996; 16:1:33–37.
    [Google Scholar]
83. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. In: Williams WJBeutler EErslev ASLichtman MA, eds. Haematology. New York: McGraw-Hill 1991.
    [Google Scholar]
84. Bayoumi RA, Nur-E-Kamal MS, Tadayyon M, Mohamed KK, Mahboob BH, Qureshi MM, Lakhani MS, Awaad MO, Kaeda J, Vulliamy TJ, Luzzatto L. Molecular characterization of erythrocyte glucose-6-phosphate dehydrogenase deficiency in Al-Ain District. United Arab Emirates. Hum Hered. 1996; 46:3:136–141.
    [Google Scholar]
85. AlFadhli S, Kaaba S, Elshafey A, Salim M, AlAwadi A, Bastaki L. Molecular characterization of glucose-6-phosphate dehydrogenase gene defect in the Kuwaiti population. Arch Pathol Lab Med. 2005; 129:9:1144–1147.
    [Google Scholar]
86. El-Hazmi MA, Al-Swailem AR, Al-Faleh FZ, Warsy AS. Frequency of glucose-6-phosphate dehydrogenase, pyruvate kinase and hexokinase deficiency in the Saudi population. Hum Hered. 1986; 36:1:45–49.
    [Google Scholar]
87. El-Hazmi MA, Warsy AS. Frequency of glucose-6-phosphate dehydrogenase variants and deficiency in Arabia. Gene Geogr. 1990; 4:1:15–19.
    [Google Scholar]
88. Karadsheh NS, Moses L, Ismail SI, Devaney JM, Hoffman E. Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan. Haematologica. 2005; 90:12:1693–1694.
    [Google Scholar]
89. Al-Allawi N, Eissa AA, Jubrael JM, Jamal SA, Hamamy H. Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. BMC Blood Disord. 2010; 10::6.
    [Google Scholar]
90. Kurdi-Haidar B, Mason PJ, Berrebi A, Ankra-Badu G, al-Ali A, Oppenheim A, Luzzatto L. Origin and spread of the glucose-6-phosphate dehydrogenase variant (G6PD-Mediterranean) in the Middle East. Am J Hum Genet. 1990; 47:6:1013–1019.
    [Google Scholar]
91. Aburawi EH. Call for multinational studies of the epidemiology of congenital heart disease in the Arab World. Ibnosina J Med BS. 2013.
    [Google Scholar]
92. Yehya A, Souki R, Bitar F, Nemer G. Differential duplication of an intronic region in the NFATC1 gene in patients with congenital heart disease. Genome. 2006; 49:9:1092–1098.
    [Google Scholar]
93. Aqrabawi HE. Facial cleft and associated anomalies: Incidence among infants at a Jordanian medical centre. East Mediterr Health J. 2008; 14:2:356–359.
    [Google Scholar]
94. Tas S. Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs. Clin Chem. 1989; 35:2:256–259.
    [Google Scholar]
95. Hussain SS, Buraiki J, Dzimiri N, Butt AI, Vencer L, Basco MC, Khan B. Polymorphism in apoprotein-CIII gene and coronary heart disease. Ann Saudi Med. 1999; 19:3:201–205.
    [Google Scholar]
96. Abu-Amero KK, Wyngaard CA, Dzimiri N. Association of the platelet glycoprotein receptor IIIa (PlA1/PlA1) genotype with coronary artery disease in Arabs. Blood Coagul Fibrinolysis. 2004; 15:1:77–79.
    [Google Scholar]
97. Al-Ali AK, Al-Muhana FA, Larbi EB, Abdulmohsen MF, Al-Sultan AI, Al-Maden MS, Al-Ateeq SA. Frequency of methylenetetrahydrofolate reductase C677T polymorphism in patients with cardiovascular disease in Eastern Saudi Arabia. Saudi Med J. 2005b; 26:12:1886–1888.
    [Google Scholar]
98. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. T null and M null genotypes of the glutathione S-transferase gene are risk factor for CAD independent of smoking. BMC Med Genet. 2006; 7::38.
    [Google Scholar]
99. Abu-Amero KK, Wyngaard CA, Al-Boudari OM, Kambouris M, Dzimiri N. Lack of association of lipoprotein lipase gene polymorphisms with coronary artery disease in the Saudi Arab population. Arch Pathol Lab Med. 2003a; 127:5:597–600.
    [Google Scholar]
100. Johansen K, Dunn B, Tan JC, Kwaasi AA, Skotnicki A, Skotnicki M. Coronary artery disease and apolipoprotein A-I/C-III gene polymorphism: A study of Saudi Arabians. Clin Genet. 1991; 39:1:1–5.
     [Google Scholar]
101. Dzimiri N, Basco C, Moorji A, Meyer BF. Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population. Arch Pathol Lab Med. 2000; 124:4:531–534.
     [Google Scholar]
102. Abu-Amero KK, Al-Boudari OM, Mohamed GH, Dzimiri N. Beta 3 adrenergic receptor Trp64Arg polymorphism and manifestation of coronary artery disease in Arabs. Hum Biol. 2005; 77:6:795–802.
     [Google Scholar]
103. Cagatay P, Susleyici-Duman B, Ciftci C. Lipoprotein lipase gene PvuII polymorphism serum lipids and risk for coronary artery disease: Meta-analysis. Dis Markers. 2007; 23:3:161–166.
     [Google Scholar]
104. Abu-Amero KK, Wyngaard CA, Dzimiri N. Prevalence and role of methylenetetrahydrofolate reductase 677 C‐‐>T and 1298 A‐‐>C polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med. 2003b; 127:10:1349–1352.
     [Google Scholar]
105. Malouf J, Alam S, Kanj H, Mufarrij A, Der Kaloustian VM. Hypergonadotropic hypogonadism with congestive cardiomyopathy: An autosomal-recessive disorder? Am J Med Genet. 1985; 20:3:483–489.
     [Google Scholar]
106. El-Menyar AA, Bener A, Numan MT, Morcos S, Taha RY, Al-Suwaidi J. Epidemiology of idiopathic cardiomyopathy in Qatar during 1996-2003. Med Princ Pract. 2006; 15:1:56–61.
     [Google Scholar]
107. Al Fadley F, Al Manea W, Nykanen DG, Al Fadley A, Bulbul Z, Al Halees Z. Severe tortuosity and stenosis of the systemic, pulmonary and coronary vessels in 12 patients with similar phenotypic features: A new syndrome? Cardiol Young. 2000; 10:6:582–589.
     [Google Scholar]
108. Coucke PJ, Wessels MW, Van Acker P, Gardella R, Barlati S, Willems PJ, Colombi M, De Paepe A. Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13. J Med Genet. 2003; 40:10:747–751.
     [Google Scholar]
109. Faiyaz-Ul-Haque M, Zaidi SH, Al-Sanna N, Alswaid A, Momenah T, Kaya N, Al-Dayel F, Bouhoaigah I, Saliem M, Tsui LC, Teebi AS. A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome. Atherosclerosis. 2009; 203:2:466–471.
     [Google Scholar]
110. Bhuiyan ZA, Momenah TS, Amin AS, Al-Khadra AS, Alders M, Wilde AA, Mannens MM. An intronic mutation leading to incomplete skipping of exon-2 in KCNQ1 rescues hearing in Jervell and Lange-Nielsen syndrome. Prog Biophys Mol Biol. 2008; 98:2-3:319–327.
     [Google Scholar]
111. Stuhrmann M, Bukhari IA, El-Harith el-HA. Naxos disease in an Arab family is not caused by the Pk2157del2 mutation. Evidence for exclusion of the plakoglobin gene. Saudi Med J. 2004; 25:10:1449–1452.
     [Google Scholar]
112. Tadmouri GO, Nair P. Cancers in Arab populations: Concise notes. Hamdan Medical J. 2012; 5:1:79–82.
     [Google Scholar]
113. Polyak K. Molecular alterations in ductal carcinoma in situ of the breast. Curr Opin Oncol. 2002; 14:1:92–96.
     [Google Scholar]
114. Ayad E, Francis I, Peston D, Shousha S. Triple negative, basal cell type and EGFR positive invasive breast carcinoma in Kuwaiti and British patients. Breast J. 2009; 15:1:109–111.
     [Google Scholar]
115. Rouba A, Kaisi N, Al-Chaty E, Badin R, Pals G, Young C, Worsham MJ. Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer. Int J Mol Med. 2000; 6:5:565–569.
     [Google Scholar]
116. Tazzite A, Jouhadi H, Nadifi S, Aretini P, Falaschi E, Collavoli A, Benider A, Caligo MA. BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variants. Gynecol Oncol. 2012; 125:3:687–692.
     [Google Scholar]
117. Uhrhammer N, Abdelouahab A, Lafarge L, Feillel V, Ben Dib A, Bignon YJ. BRCA1 mutations in Algerian breast cancer patients: High frequency in young, sporadic cases. Int J Med Sci. 2008; 5:4:197–202.
     [Google Scholar]
118. Troudi W, Uhrhammer N, Romdhane KB, Sibille C, Amor MB, Khodjet El Khil H, Jalabert T, Mahfoudh W, Chouchane L, Ayed FB, Bignon YJ, Elgaaied AB. Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. Cancer Biomark. 2008; 4:1:11–18.
     [Google Scholar]
119. Mahfoudh W, Bouaouina N, Ahmed SB, Gabbouj S, Shan J, Mathew R, Uhrhammer N, Bignon YJ, Troudi W, Elgaaied AB, Hassen E, Chouchane L. Hereditary breast cancer in Middle Eastern and North African (MENA) populations: Identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population. Mol Biol Rep. 2012; 39:2:1037–1046.
     [Google Scholar]
120. Chouchane L, Boussen H, Sastry KS. Breast cancer in Arab populations: Molecular characteristics and disease management implications. Lancet Oncol. 2013; 14:10:e417–e424.
     [Google Scholar]
121. Kadouri L, Bercovich D, Elimelech A, Lerer I, Sagi M, Glusman G, Shochat C, Korem S, Hamburger T, Nissan A, Abu-Halaf N, Badrriyah M, Abeliovich D, Peretz T. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer. BMC Cancer. 2007; 7::14.
     [Google Scholar]
122. Jalkh N, Nassar-Slaba J, Chouery E, Salem N, Uhrchammer N, Golmard L, Stoppa-Lyonnet D, Bignon YJ, Mégarbané A. Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon. Hered Cancer Clin Pract. 2012; 10:1:7.
     [Google Scholar]
123. El-Harith el-HA, Abdel-Hadi MS, Steinmann D, Dork T. BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. Saudi Med J. 2002; 23:6:700–704.
     [Google Scholar]
124. Riahi A, Kharrat M, Ghourabi ME, Khomsi F, Gamoudi A, Lariani I, May AE, Rahal K, Chaabouni-Bouhamed H. Mutation spectrum and prevalence of BRCA1 and BRCA2 genes in patients with familial and early-onset breast/ovarian cancer from Tunisia. Clin Genet. 2013;, Dec 28.
     [Google Scholar]
125. Shatavi SV, Dohany L, Chisti MM, Jaiyesimi IA, Zakalik D. Unique genetic characteristics of BRCA mutation carriers in a cohort of Arab American women. J Clin Oncol. 2013; 31:suppl:abstr 1541.
     [Google Scholar]
126. Al-Qasem AJ, Toulimat M, Eldali AM, Tulbah A, Al-Yousef N, Al-Daihan SK, Al-Tassan N, Al-Tweigeri T, Aboussekhra A. TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution. Oncol Lett. 2011; 2:2:363–369.
     [Google Scholar]
127. Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol. 2006; 67:1-2:13–21.
     [Google Scholar]
128. AlShatwi AA, Hasan TN, Shafi G, Alsaif MA, Al-Hazzani AA, Alsaif AA. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population. Fundam Clin Pharmacol. 2012; 26:3:438–443.
     [Google Scholar]
129. Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol. 2012; 33:4:1133–1139.
     [Google Scholar]
130. Levine DA, Bogomolniy F, Yee CJ, Lash A, Barakat RR, Borgen PI, Boyd J. Frequent mutation of the PIK3CA gene in ovarian and breast cancers. Clin Cancer Res. 2005; 11:8:2875–2878.
     [Google Scholar]
131. Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL. PIK3CA mutations in advanced ovarian carcinomas. Hum Mutat. 2005; 25:3:322.
     [Google Scholar]
132. Abubaker J, Bavi P, Al-Haqawi W, Jehan Z, Munkarah A, Uddin S, Al-Kuraya KS. PIK3CA alterations in Middle Eastern ovarian cancers. Mol Cancer. 2009; 8::51.
     [Google Scholar]
133. Teebi AS. Genetic disorders among Arab populations. Second Edition. Berlin, Heidelberg, Germany: Springer-Verlag 2010.
     [Google Scholar]
134. Laarabi FZ, Cherkaoui Jaouad I, Baert-Desurmont S, Ouldim K, Ibrahimi A, Kanouni N, Frebourg T, Sefiani A. The first mutations in the MYH gene reported in Moroccan colon cancer patients. Gene. 2012; 496:1:55–58.
     [Google Scholar]
135. Aissi-Ben Moussa S, Moussa A, Lovecchio T, Kourda N, Najjar T, Ben Jilani S, El Gaaied A, Porchet N, Manai M, Buisine MP. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: Evidence for a homologous Alu-mediated recombination. Fam Cancer. 2009; 8:2:119–126.
     [Google Scholar]
136. Bougatef K, Marrakchi R, Ouerhani S, Sassi R, Moussa A, Kourda N, Blondeau Lahely Y, Najjar T, Ben Jilani S, Soubrier F, Ben Ammar Elgaaied A. No evidence of the APC D1822V missense variant's pathogenicity in Tunisian patients with sporadic colorectal cancer. Pathol Biol (Paris). 2009; 57:3:e67–e71.
     [Google Scholar]
137. Patael Y, Figer A, Gershoni-Baruch R, Papa MZ, Risel S, Shtoyerman-Chen R, Karasik A, Theodor L, Friedman E. Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi Jews. Eur J Hum Genet. 1999; 7:5:555–559.
     [Google Scholar]
138. Drucker L, Shpilberg O, Neumann A, Shapira J, Stackievicz R, Beyth Y, Yarkoni S. Adenomatous polyposis coli I1307K mutation in Jewish patients with different ethnicity: Prevalence and phenotype. Cancer. 2000; 88:4:755–760.
     [Google Scholar]
139. Niell BL, Long JC, Rennert G, Gruber SB. Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: Evidence of genetic drift within the Ashkenazim. Am J Hum Genet. 2003; 73:6:1250–1260.
     [Google Scholar]
140. Chan AO, Soliman AS, Zhang Q, Rashid A, Bedeir A, Houlihan PS, Mokhtar N, Al-Masri N, Ozbek U, Yaghan R, Kandilci A, Omar S, Kapran Y, Dizdaroglu F, Bondy ML, Amos CI, Issa JP, Levin B, Hamilton SR. Differing DNA methylation patterns and gene mutation frequencies in colorectal carcinomas from Middle Eastern countries. Clin Cancer Res. 2005; 11:23:8281–8287.
     [Google Scholar]
141. Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine. 2006; 35:1-2:21–28.
     [Google Scholar]
142. Sfar S, Saad H, Mosbah F, Gabbouj S, Chouchane L. TSP1 and MMP9 genetic variants in sporadic prostate cancer. Cancer Genet Cytogenet. 2007; 172:1:38–44.
     [Google Scholar]
143. Al-Dayel F, Al-Rasheed M, Ibrahim M, Bu R, Bavi P, Abubaker J, Al-Jomah N, Mohamed GH, Moorji A, Uddin S, Siraj AK, Al-Kuraya K. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population. Leuk Lymphoma. 2008; 49:1:122–129.
     [Google Scholar]
144. Siraj AK, Ibrahim M, Al-Rasheed M, Abubaker J, Bu R, Siddiqui SU, Al-Dayel F, Al-Sanea O, Al-Nuaim A, Uddin S, Al-Kuraya K. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. BMC Med Genet. 2008; 9::61.
     [Google Scholar]
145. Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M, Hassine LB, Ayed M, Elgaaïed AB. The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol. 2006; 33:5-6:529–535.
     [Google Scholar]
146. Ouerhani S, Oliveira E, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, El Gaaied AB, Prata MJ. Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet. 2007; 176:1:48–53.
     [Google Scholar]
147. Ozçelik T, Kanaan M, Avraham KB, Yannoukakos D, Mégarbané A, Tadmouri GO, Middleton L, Romeo G, King MC, Levy-Lahad E. Collaborative genomics for human health and cooperation in the Mediterranean region. Nat Genet. 2010; 42:8:641–645.
     [Google Scholar]